NCT01270711View on ClinicalTrials.gov

Study On Utilization Of Cabergoline For Compliance With Risk Minimization Activities (SUCRE)

CompletedOBSERVATIONAL
Enrollment

22,014

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Parkinson's DiseaseHyperprolactinemia
Interventions
DRUG

Study Drug

non interventional study - usage as per usual care

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY